Dianthus Therapeutics, Inc. /DE/ (DNTH) Operating margin 2021–2025
Dianthus Therapeutics, Inc. /DE/ (DNTH) operating margin by fiscal year — reported operating income divided by reported revenue.
-8739.3%FY2025 · since FY2021: -5060.4% → -8739.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8739.3% | -7105.6 pp |
| FY2024 | -1633.7% | +70.9 pp |
| FY2023 | -1704.7% | -1241.8 pp |
| FY2022 | -462.9% | +4597.5 pp |
| FY2021 | -5060.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DNTH financial trends
DNTH RevenueDNTH Net incomeDNTH Net marginDNTH Gross profitDNTH Gross marginDNTH Operating incomeDNTH Operating cash flowDNTH Free cash flowDNTH Capital expendituresDNTH Return on equityDNTH Stock buybacksDNTH Dividends paidDNTH Total assetsDNTH Total liabilitiesDNTH Shareholders’ equityDNTH overview →